Brief: Hanmi Pharm Q3 Operating Loss 32 Billion Won, Swings To Loss From Year Earlier
Oct 30 (Reuters) -
* HANMI PHARM: Q3 OPERATING LOSS 32 BILLION WON, SWINGS TO
LOSS
FROM YEAR EARLIER
Source text for Eikon: ID:
Further company coverage: 128940.KS
(Reporting by Joyce Lee)
((JungYoon.Lee@thomsonreuters.com;))
Recent news on Hanmi Pharm
See all newsBrief: Hanmi Pharm To Cancel 28 Billion Won Worth Of Own Shares
Brief: Hanmi Pharm Q3 Operating Profit 37.8 Billion Won, Down 31.3% From Year Earlier
Brief: Hanmi Pharm Co Signs License Out Agreement With Genetech Inc. In U.S.
Brief: Hanmi Pharm Co Enters License Agreement With Eli Lilly For Sonefpeglutide
Brief: Hanmi Pharm Co Ltd Wins 53 Billion Won Order